The I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders, reports this month's issue of the Alimentary Pharmacology & Therapeutics.
Biological therapy increases the health-related quality of life in patients with inflammatory bowel disease in a clinical setting, reports March's issue of the Scandanavian Journal of Gastroenterology.
A risk-scoring system combined with a fecal immunochemical test is effective in screening high-risk subjects for early colonoscopy to detect advanced colorectal neoplasms, finds March's issue of Gastroenterology.
Response to glucocorticoid therapy in IBD may depend on gene variability encoding proteins involved in the function and metabolism of glucocorticoids, reports the most recent issue of the Scandanavian Journal of Gastroenterology.
Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD, reports one of the recent publications of Alimentary Pharmacology & Therapeutics.